Literature DB >> 20523270

Pathophysiological roles of peroxynitrite in circulatory shock.

Csaba Szabó1, Katalin Módis.   

Abstract

Peroxynitrite is a reactive oxidant produced from nitric oxide and superoxide, which reacts with proteins, lipids, and DNA, and promotes cytotoxic and proinflammatory responses. Here, we overview the role of peroxynitrite in various forms of circulatory shock. Immunohistochemical and biochemical evidences demonstrate the production of peroxynitrite in various experimental models of endotoxic and hemorrhagic shock both in rodents and in large animals. In addition, biological markers of peroxynitrite have been identified in human tissues after circulatory shock. Peroxynitrite can initiate toxic oxidative reactions in vitro and in vivo. Initiation of lipid peroxidation, direct inhibition of mitochondrial respiratory chain enzymes, inactivation of glyceraldehyde-3-phosphate dehydrogenase, inhibition of membrane Na+/K+ ATPase activity, inactivation of membrane sodium channels, and other oxidative protein modifications contribute to the cytotoxic effect of peroxynitrite. In addition, peroxynitrite is a potent trigger of DNA strand breakage, with subsequent activation of the nuclear enzyme poly(ADP-ribose) polymerase, which promotes cellular energetic collapse and cellular necrosis. Additional actions of peroxynitrite that contribute to the pathogenesis of shock include inactivation of catecholamines and catecholamine receptors (leading to vascular failure) and endothelial and epithelial injury (leading to endothelial and epithelial hyperpermeability and barrier dysfunction), as well as myocyte injury (contributing to loss of cardiac contractile function). Neutralization of peroxynitrite with potent peroxynitrite decomposition catalysts provides cytoprotective and beneficial effects in rodent and large-animal models of circulatory shock.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20523270      PMCID: PMC4226740          DOI: 10.1097/SHK.0b013e3181e7e9ba

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  185 in total

1.  Effects of the inducible nitric-oxide synthase inhibitor L-N(6)-(1-iminoethyl)-lysine on microcirculation and reactive nitrogen species generation in the kidney following lipopolysaccharide administration in mice.

Authors:  Liping Wu; Philip R Mayeux
Journal:  J Pharmacol Exp Ther       Date:  2007-01-03       Impact factor: 4.030

2.  Peroxynitrite-induced cardiac myocyte injury.

Authors:  H Ishida; K Ichimori; Y Hirota; M Fukahori; H Nakazawa
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

3.  Peroxynitrite diminishes myogenic tone in cerebral arteries: role of nitrotyrosine and F-actin.

Authors:  Matthew J Maneen; Marilyn J Cipolla
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-10-13       Impact factor: 4.733

4.  Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts.

Authors:  L A MacMillan-Crow; J P Crow; J D Kerby; J S Beckman; J A Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 5.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

6.  The potential role of peroxynitrite in the vascular contractile and cellular energetic failure in endotoxic shock.

Authors:  B Zingarelli; B J Day; J D Crapo; A L Salzman; C Szabó
Journal:  Br J Pharmacol       Date:  1997-01       Impact factor: 8.739

7.  Clinical evidence of peroxynitrite formation in chronic renal failure patients with septic shock.

Authors:  N Fukuyama; Y Takebayashi; M Hida; H Ishida; K Ichimori; H Nakazawa
Journal:  Free Radic Biol Med       Date:  1997       Impact factor: 7.376

Review 8.  Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease.

Authors:  Pal Pacher; Csaba Szabo
Journal:  Am J Pathol       Date:  2008-06-05       Impact factor: 4.307

9.  Novel ovine model of methicillin-resistant Staphylococcus aureus-induced pneumonia and sepsis.

Authors:  Perenlei Enkhbaatar; Collette Joncam; Lillian Traber; Yoshimitsu Nakano; Jianpu Wang; Matthias Lange; Rhykka Connelly; Gabriela Kulp; Fiona Saunders; Ruksana Huda; Robert Cox; Frank Schmalstieg; David Herndon; Daniel Traber
Journal:  Shock       Date:  2008-05       Impact factor: 3.454

Review 10.  Liver perfusion in sepsis, septic shock, and multiorgan failure.

Authors:  Herbert Spapen
Journal:  Anat Rec (Hoboken)       Date:  2008-06       Impact factor: 2.064

View more
  47 in total

1.  Beneficial pulmonary effects of a metalloporphyrinic peroxynitrite decomposition catalyst in burn and smoke inhalation injury.

Authors:  Matthias Lange; Csaba Szabo; Perenlei Enkhbaatar; Rhykka Connelly; Eszter Horvath; Atsumori Hamahata; Robert A Cox; Aimalohi Esechie; Yoshimitsu Nakano; Lillian D Traber; David N Herndon; Daniel L Traber
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-11-12       Impact factor: 5.464

2.  Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure.

Authors:  Olav Albert Christophersen
Journal:  Microb Ecol Health Dis       Date:  2012-02-01

3.  Resveratrol Improves Survival and Prolongs Life Following Hemorrhagic Shock.

Authors:  Ahmar Ayub; Ninu Poulose; Raghavan Raju
Journal:  Mol Med       Date:  2015-04-13       Impact factor: 6.354

4.  Oxidative stress injury after on-pump cardiac surgery: effects of aortic cross clamp time and type of surgery.

Authors:  José García-de-la-Asunción; Ernesto Pastor; Jaime Perez-Griera; Francisco Javier Belda; Tania Moreno; Eva García-del-Olmo; Francisco Martí
Journal:  Redox Rep       Date:  2013       Impact factor: 4.412

5.  Post-translational oxidative modification of fibrinogen is associated with coagulopathy after traumatic injury.

Authors:  Nathan J White; Yi Wang; Xiaoyun Fu; Jessica C Cardenas; Erika J Martin; Donald F Brophy; Charles E Wade; Xu Wang; Alexander E St John; Esther B Lim; Susan A Stern; Kevin R Ward; José A López; Dominic Chung
Journal:  Free Radic Biol Med       Date:  2016-04-20       Impact factor: 7.376

Review 6.  Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.

Authors:  Nathan A Berger; Valerie C Besson; A Hamid Boulares; Alexander Bürkle; Alberto Chiarugi; Robert S Clark; Nicola J Curtin; Salvatore Cuzzocrea; Ted M Dawson; Valina L Dawson; György Haskó; Lucas Liaudet; Flavio Moroni; Pál Pacher; Peter Radermacher; Andrew L Salzman; Solomon H Snyder; Francisco Garcia Soriano; Robert P Strosznajder; Balázs Sümegi; Raymond A Swanson; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2017-03-26       Impact factor: 8.739

7.  NS-398 reverses hypotension in endotoxemic rats: contribution of eicosanoids, NO, and peroxynitrite.

Authors:  Bahar Tunctan; Ayse Nihal Sari; Meltem Kacan; Demet Unsal; C Kemal Buharalioglu; Seyhan Sahan-Firat; Belma Korkmaz; John R Falck; Kafait U Malik
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-09-05       Impact factor: 3.072

8.  AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro.

Authors:  Bartosz Szczesny; Katalin Módis; Kazunori Yanagi; Ciro Coletta; Sophie Le Trionnaire; Alexis Perry; Mark E Wood; Matthew Whiteman; Csaba Szabo
Journal:  Nitric Oxide       Date:  2014-04-19       Impact factor: 4.427

9.  The peroxynitrite catalyst WW-85 improves microcirculation in ovine smoke inhalation injury and septic shock.

Authors:  Dirk M Maybauer; Marc O Maybauer; Csaba Szabó; Martin Westphal; Lillian D Traber; Andrew L Salzman; David N Herndon; Daniel L Traber
Journal:  Burns       Date:  2011-02-22       Impact factor: 2.744

10.  Right man, right time, right place?--on the time course of the mediator orchestra in septic shock.

Authors:  Balázs Hauser; Peter Radermacher
Journal:  Crit Care       Date:  2010-08-23       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.